EUVIMEDEUVIMED entdecken
Crossref

Putative cutaneous adverse drug reaction suspected to be secondary to drug excipient and responding to brand change of pimobendan in a dog with hyperkeratotic erythema multiforme

Louis Humeau, Noëlle Cochet‐Faivre

Veterinary Record Case Reports · 2026-02 · 14 (1)

DOI: 10.1002/vrc2.70267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Record Case Reports, online erschienen am 15.11.2025. Verfasst von Louis Humeau und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 16‐year‐old, spayed, female mixed terrier dog was presented with a 4‐month history of hyperkeratotic, pigmented raised papules and plaques. Histopathological examination of skin biopsies revealed a hyperplastic panepidermal cytotoxic lymphocytic dermatitis compatible with hyperkeratotic erythema multiforme. The patient had started treatment with pimobendan 2 weeks before the appearance of the lesions. A brand change of pimobendan resulted in complete healing of the lesions within 3 weeks without any treatment. This case highlights the importance of considering excipients as potential sources of cutaneous adverse drug reactions.

Zitieren

APA

Humeau, L., & Cochet‐Faivre, N. (2026). Putative cutaneous adverse drug reaction suspected to be secondary to drug excipient and responding to brand change of pimobendan in a dog with hyperkeratotic erythema multiforme. Veterinary Record Case Reports, 14(1). https://doi.org/10.1002/vrc2.70267

Vancouver

Humeau L, Cochet‐Faivre N. Putative cutaneous adverse drug reaction suspected to be secondary to drug excipient and responding to brand change of pimobendan in a dog with hyperkeratotic erythema multiforme. Veterinary Record Case Reports. 2026;14(1). doi:10.1002/vrc2.70267

BibTeX
@article{Humeau2026,
  author = {Humeau, Louis and Cochet‐Faivre, Noëlle},
  title = {Putative cutaneous adverse drug reaction suspected to be secondary to drug excipient and responding to brand change of pimobendan in a dog with hyperkeratotic erythema multiforme},
  journal = {Veterinary Record Case Reports},
  year = {2026},
  volume = {14},
  number = {1},
  doi = {10.1002/vrc2.70267}
}
Kostenlos starten →